P. 1

    August-October 2021
  MRIN-UPH Participates in the Discovery of Antiserum IgY as an alternative therapy for Covid-19
Aresearcher in the Immunology Division of the Mochtar Riady Institute for Nanotechnology Universitas Pelita Harapan (MRIN-UPH), dr. Teridah E. Ginting, DVM, PhD, joined a national consortium with Kamaludin Zarkasie (a researcher from PT IPB Shigeta), to study the Immunoglobulin Y (IgY) antiserum. This study commenced in June 2020 and with the aim of producing IgY antiserum from chicken as an alternative treatment to Covid-19.
“The process involves injecting immunogen into laying hens and
harvesting the yolk of the eggs. We then extract the antibody produced against the immunogen injected from the yolk, based on the findings of this study,” explains dr. Teridah.
Antiserum IgY is a promising candidate to create an antiserum treatment for Covid-19, because it is stable at pH 4-9 and up to 65 degrees Celsius in solution, which effectively binds to antigens, is resistant to pepsin at pH 4-6. In addition, IgY has the same function as immunoglobulin G (IgG) produced by mammals. Read more

   1   2   3